Advertisement

Topics

Arakis Limited Company Profile

22:54 EDT 21st September 2017 | BioPortfolio

Arakis is an emerging pharmaceutical company, founded in March 2000 to create, protect, develop and commercialise innovative market orientated, therapeutic products - which are termed Performance Enhanced Medicines (PEM). Arakis is exploiting advances in the understanding of disease biology alongside a novel product development approach to generate a wave of new therapies that are suited to patient needs and which are ever more relevant as trends in healthcare lead towards "personalised medicine".

Arakis has created a pipeline of PEM developments along with an extensive database of PEM product concepts to fuel future growth. Arakis intends to maintain a broad but balanced portfolio of PEMs in development, many through co-development alliances with strategic partners. Arakis currently has eight programmes in development and more than three hundred other PEM product concepts at various stages of evaluation.

Location

Chesterfield Research Park, Little Chesterfield
Safron Waldon
Essex
CB10 1XL
United Kingdom

Contact

Phone: 44 (0) 1799 532 350
Fax: 44 (0) 1799 532 351
Email: enquiries@arakis.com


News Articles [14 Associated News Articles listed on BioPortfolio]

Quotient Limited to Participate in the UBS Global Healthcare Conference

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited to Participate in the Jefferies 2017 Global Healthcare Conference

JERSEY, Channel Islands, May 31, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

Quotient Limited to Report Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and ...

Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results

Initial MosaiQ manufacturing system commissioned and validatedFirst “commercially ready” MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expe...

Quotient Limited Reports Results From Latest MosaiQ Performance Evaluation Studies Prior to Commencing Verification and Validation Studies

Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [82 Associated Companies listed on BioPortfolio]

Arakis Limited

Arakis is an emerging pharmaceutical company, founded in March 2000 to create, protect, develop and commercialise innovative market orientated, therapeutic products - which are termed Performance Enha...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Arakis Limited" on BioPortfolio

We have published hundreds of Arakis Limited news stories on BioPortfolio along with dozens of Arakis Limited Clinical Trials and PubMed Articles about Arakis Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Arakis Limited Companies in our database. You can also find out about relevant Arakis Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record